Building a global network for paediatric rheumatology research
PReS Network for Trial and Research (PReSTaR) is an independent academic clinical research stemming from a collaboration of the Paediatric Rheumatology European Society and IRCCS Istituto Giannina Gaslini.
The key objective of PReSTaR is to support clinical research in paediatric rheumatology through a network involving international clinical and academic centres, as well as all PReS working parties.
We support investigator-initiated trials and collaborative studies that aim to improve care for children with rheumatic diseases.
We develop and manage clinical databases and disease registries with integrated biobanking, ensuring data quality and long-term impact.
In partnership with all PReS Working Parties, we coordinate efforts among clinical and academic centers to standardize and accelerate research.
We work together with pharma companies supporting the design, the development and the implementation of clinical trials and post marketing registries.
At PReSTaR, we believe that co-producing research with patients and caregivers is essential. We foster an environment of mutual respect where patients collaborate with researchers throughout the entire lifecycle of each project.
Patients and caregivers participate from the earliest stages of project conception, ensuring research addresses real-world needs.
Patients help develop recruitment strategies and study materials, making research more accessible and participant-friendly.
Patients participate in disseminating study findings to the community, ensuring research impact reaches those who need it most.
PReSTaR coordinates and supports international clinical research projects designed to improve outcomes for children with rheumatic diseases. Learn more about our ongoing initiatives and how we work with investigators and institutions across Europe.